Heidelberg Pharma AG (HPHA) — Capital Reinvestment Ratio

Latest as of May 2022: 0.00x

Heidelberg Pharma AG (HPHA) has a Capital Reinvestment Ratio of 0.00x as of May 2022, meaning it reinvests 0% of its operating cash flow (€13.59 Million) in capital expenditures (€50.81K). See Heidelberg Pharma AG (HPHA) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

€13.59 Million
EUR

Capital Expenditures

€50.81K
EUR

Data as of

May 2022
Most recent filing

Annual Capital Reinvestment Ratio for Heidelberg Pharma AG (None–None)

Year-by-year Capital Reinvestment Ratio for Heidelberg Pharma AG from None to None. For live market cap and broader valuation context, see Heidelberg Pharma AG market cap and net worth.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow